Fig. 7 | Scientific Reports

Fig. 7

From: Synergistic combinatorial anticancer potential of Tamoxifen with Naringin and Diosmetin in MCF-7 breast cancer cells and their liposomal delivery

Fig. 7

Cell viability (%) of HEK-293 and MCF-7 cells treated with formulations. (A) Cell viability (%) of HEK-293 normal cells and (B) MCF-7 breast cancer cells after treatment with liposomal formulations. TMX-Lipo (Tamoxifen loaded liposome); T + N-Lipo (Tmaxifen+Naringin loaded liposome); T + D-Lipo (Tmaxifen + Diosmetin loaded liposome); T +  N + D-Lipo (Tmaxifen + Naringin + Diosmetin loaded liposome). Data are represented as mean ± SD from three independent experiments. Statistical significance compared with the untreated control: p < 0.001 (***), and p < 0.0001 (****).

Back to article page